2019 Q2 Form 10-K Financial Statement

#000143774919007308 Filed on April 16, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 2017 Q4
Revenue $62.72K $6.090M
YoY Change 3.75%
Cost Of Revenue $33.45K $2.410M
YoY Change 10.05%
Gross Profit $29.27K $3.680M
YoY Change 0.0%
Gross Profit Margin 46.67% 60.43%
Selling, General & Admin $605.8K $1.292M $3.080M
YoY Change 147.15% -88.99% 15.36%
% of Gross Profit 2069.72% 83.7%
Research & Development $4.166M $1.210M
YoY Change -5.63% 13.08%
% of Gross Profit 32.88%
Depreciation & Amortization $197.00 $0.00 $100.0K
YoY Change -98.31% -100.0% -58.33%
% of Gross Profit 0.67% 2.72%
Operating Expenses $605.8K $1.292M $4.270M
YoY Change 147.15% -92.0% 14.17%
Operating Profit -$576.6K -$1.292M -$590.0K
YoY Change 135.21% 16.94% 883.33%
Interest Expense -$350.0K
YoY Change -35.19%
% of Operating Profit
Other Income/Expense, Net $56.00 $118.00 $0.00
YoY Change 124.0% -100.01%
Pretax Income -$576.5K -$1.292M -$1.060M
YoY Change 135.21% -46.72% -62.14%
Income Tax
% Of Pretax Income
Net Earnings $14.62M -$11.42M -$1.060M
YoY Change -1034.64% 370.92% -62.14%
Net Earnings / Revenue 23307.14% -17.41%
Basic Earnings Per Share -$0.17
Diluted Earnings Per Share $209.2K -$0.17 -$16.16K
COMMON SHARES
Basic Shares Outstanding 66.18M 66.06M
Diluted Shares Outstanding 66.06M

Balance Sheet

Concept 2019 Q2 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.251M $27.30K $170.0K
YoY Change 22.66% -83.64% -89.88%
Cash & Equivalents $1.251M $166.9K
Short-Term Investments
Other Short-Term Assets $123.2K $2.386M $600.0K
YoY Change -78.38% 298.82% 33.33%
Inventory
Prepaid Expenses
Receivables $51.56K $0.00 $2.693M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.426M $2.414M $3.458M
YoY Change -68.24% -30.2% -20.65%
LONG-TERM ASSETS
Property, Plant & Equipment $3.738K $0.00 $69.41K
YoY Change -94.87% -100.0% -53.46%
Goodwill $3.805M
YoY Change
Intangibles $3.926M
YoY Change 41.0%
Long-Term Investments
YoY Change
Other Assets $0.00 $160.3K $123.1K
YoY Change -100.0% 30.16% 20.03%
Total Long-Term Assets $3.809M $160.2K $4.118M
YoY Change -16.07% -96.11% 35.65%
TOTAL ASSETS
Total Short-Term Assets $1.426M $2.414M $3.458M
Total Long-Term Assets $3.809M $160.2K $4.118M
Total Assets $5.234M $2.574M $7.576M
YoY Change -42.01% -66.03% 2.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $152.6K $0.00 $2.480M
YoY Change -93.8% -100.0% -6.06%
Accrued Expenses
YoY Change
Deferred Revenue $21.34K $299.9K
YoY Change -97.02%
Short-Term Debt $0.00 $0.00 $1.220M
YoY Change -100.0% 139.22%
Long-Term Debt Due $3.060M
YoY Change 50.0%
Total Short-Term Liabilities $557.0K $6.861M $7.059M
YoY Change -91.54% -2.8% 34.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $4.670M
YoY Change -100.0% -100.0% 1.74%
Other Long-Term Liabilities $9.186M $1.063M
YoY Change 764.54% -28.57%
Total Long-Term Liabilities $0.00 $9.186M $1.063M
YoY Change -100.0% 60.21% -28.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $557.0K $6.861M $7.059M
Total Long-Term Liabilities $0.00 $9.186M $1.063M
Total Liabilities $557.0K $16.05M $12.79M
YoY Change -96.25% 25.44% 13.07%
SHAREHOLDERS EQUITY
Retained Earnings -$29.36M -$31.54M
YoY Change -14.55% 8.33%
Common Stock $99.68K $65.94K
YoY Change 51.17% 3.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.677M -$13.47M -$5.217M
YoY Change
Total Liabilities & Shareholders Equity $5.234M $2.574M $7.576M
YoY Change -42.01% -66.03% 2.47%

Cashflow Statement

Concept 2019 Q2 2018 2017 Q4
OPERATING ACTIVITIES
Net Income $14.62M -$11.42M -$1.060M
YoY Change -1034.64% 370.92% -62.14%
Depreciation, Depletion And Amortization $197.00 $0.00 $100.0K
YoY Change -98.31% -100.0% -58.33%
Cash From Operating Activities -$5.750M -$3.460M -$510.0K
YoY Change 627.84% 135.38% -204.08%
INVESTING ACTIVITIES
Capital Expenditures -$1.750K -$20.00K
YoY Change -91.25%
Acquisitions
YoY Change
Other Investing Activities $20.47M -$1.353M -$360.0K
YoY Change -5633.15% -21.02% -7.69%
Cash From Investing Activities $20.47M -$1.389M -$390.0K
YoY Change -5348.95% -21.81% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -14.01M 4.746M 430.0K
YoY Change -1079.89% 179.57% -56.12%
NET CHANGE
Cash From Operating Activities -5.750M -3.460M -510.0K
Cash From Investing Activities 20.47M -1.389M -390.0K
Cash From Financing Activities -14.01M 4.746M 430.0K
Net Change In Cash 708.5K -139.6K -470.0K
YoY Change 183.39% -90.78% -143.52%
FREE CASH FLOW
Cash From Operating Activities -$5.750M -$3.460M -$510.0K
Capital Expenditures -$1.750K -$20.00K
Free Cash Flow -$5.748M -$3.460M -$490.0K
YoY Change 646.52% 125.64% -200.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2400000
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
9075828
CY2018 aclz Accured Payables And Loans Paid By Credit Facility
AccuredPayablesAndLoansPaidByCreditFacility
680149
CY2017 aclz Accured Payables And Loans Paid By Credit Facility
AccuredPayablesAndLoansPaidByCreditFacility
CY2017 aclz Adjustments To Additional Paid In Capital Sharebased Compensation Warrants Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationWarrantsRequisiteServicePeriodRecognition
566860
CY2018 aclz Adjustments To Additional Paid In Capital Sharebased Compensation Warrants Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationWarrantsRequisiteServicePeriodRecognition
318441
CY2018Q4 aclz Deferred Finance Costs Related Party Noncurrent Net
DeferredFinanceCostsRelatedPartyNoncurrentNet
163314
CY2017Q4 aclz Deferred Finance Costs Related Party Noncurrent Net
DeferredFinanceCostsRelatedPartyNoncurrentNet
0
CY2018 aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
469041
CY2017 aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
862859
CY2018 aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
2727577
CY2017 aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
104676
CY2018 aclz Other Finance Fees
OtherFinanceFees
CY2017 aclz Other Finance Fees
OtherFinanceFees
125000
CY2018 aclz Prepaid Expenses Reclassified To Deferred Financing Costs
PrepaidExpensesReclassifiedToDeferredFinancingCosts
70000
CY2017 aclz Prepaid Expenses Reclassified To Deferred Financing Costs
PrepaidExpensesReclassifiedToDeferredFinancingCosts
CY2018 aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
CY2017 aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
25000
CY2017 aclz Stock Issued During Period Shares Stock Options Exercised Noncash
StockIssuedDuringPeriodSharesStockOptionsExercisedNoncash
1707692
CY2018 aclz Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
160096
CY2017 aclz Stock Issued During Period Shares Warrants Exercised Noncash
StockIssuedDuringPeriodSharesWarrantsExercisedNoncash
160096
CY2017 aclz Stock Issued During Period Value Stock Options And Warrants Exercised Noncash
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercisedNoncash
CY2018Q4 aclz Working Capital Deficit
WorkingCapitalDeficit
4447678
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66179709
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q2 dei Entity Public Float
EntityPublicFloat
16490753
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3018394
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2479083
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2081551
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2692636
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
783275
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
775152
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-77355
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41540
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29498125
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26301748
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
295999
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
150600
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
104676
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2727577
CY2018 us-gaap Advertising Cost Policy Expensed Advertising Cost
AdvertisingCostPolicyExpensedAdvertisingCost
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; text-decoration: underline;">Advertising</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The Company expenses advertising costs as incurred.&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div> <table style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2017</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Advertising expense</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">742,200</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">604,300</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div></div></div></div></div></div></div>
CY2018 us-gaap Advertising Expense
AdvertisingExpense
742200
CY2017 us-gaap Advertising Expense
AdvertisingExpense
604300
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
245736
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
471144
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18966
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
443650
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
943377
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
249125
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27626932
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17273444
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4724746
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
CY2018Q4 us-gaap Assets
Assets
2573852
CY2017Q4 us-gaap Assets
Assets
7575914
CY2018Q4 us-gaap Assets Current
AssetsCurrent
2413606
CY2017Q4 us-gaap Assets Current
AssetsCurrent
3457862
CY2018 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
554389
CY2017 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
572246
CY2018Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4725000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27295
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166883
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1680127
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
216883
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1730127
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
77295
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-139588
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1513244
CY2018Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66179709
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65939709
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66179709
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65939709
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
66179
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
65938
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11453255
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2388699
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risks</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.5pt 0pt -2pt; text-align: left; text-indent: 37.5pt;">The Company is subject to concentrations of credit risk primarily from cash, cash equivalents and accounts receivable.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.5pt 0pt -2pt; text-align: left; text-indent: 37.5pt;">The Company&#x2019;s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,000.</div> During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of financial institutions in which it holds deposits.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.5pt 0pt -2pt; text-align: left; text-indent: 37.5pt;">The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div> of the Company&#x2019;s customers accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of its accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div>&nbsp;The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require any collateral from its customers.</div></div></div></div></div></div></div></div></div>
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
299937
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
443650
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
299937
CY2018Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1135000
CY2018Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
497472
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
9066896
CY2018 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
75000
CY2017 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2018Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
1522740
CY2017Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
245584
CY2018Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2017Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2018Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
676598
CY2017Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
82868
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10771177
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7321567
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6012765
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4377202
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2733185
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1058115
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2025227
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1886250
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10771177
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7321567
CY2018 us-gaap Depreciation
Depreciation
49868
CY2017 us-gaap Depreciation
Depreciation
130037
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
604258
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
707081
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2018 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-35814
CY2017 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35789
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.209
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-1.207
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.003
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
10636
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y270D
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8298748
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3925523
CY2018 us-gaap Interest Expense Debt
InterestExpenseDebt
2581046
CY2017 us-gaap Interest Expense Debt
InterestExpenseDebt
1214476
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-997
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10027
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-106034
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4724746
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2512203
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6437726
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3925523
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7349754
CY2018 us-gaap Gross Profit
GrossProfit
12653777
CY2017 us-gaap Gross Profit
GrossProfit
15037728
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4724746
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
CY2018Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
221234
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-612543
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-836493
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
346515
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
143713
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
246487
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-14910
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
20548
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-223583
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
150156
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1776293
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3460496
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1470182
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-11417440
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-2424488
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2580425
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1319762
CY2018Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
386686
CY2018 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1578878
CY2017 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
851544
CY2018 us-gaap Interest Paid Net
InterestPaidNet
1578878
CY2017 us-gaap Interest Paid Net
InterestPaidNet
851544
CY2018Q4 us-gaap Liabilities
Liabilities
16047027
CY2017Q4 us-gaap Liabilities
Liabilities
12792452
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2573852
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7575914
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6861284
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7059026
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3399240
CY2017Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3055812
CY2018Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
5888155
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4402988
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4745602
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1697442
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1388880
CY2017Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
CY2018 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2018 us-gaap Operating Expenses
OperatingExpenses
21490792
CY2017 us-gaap Operating Expenses
OperatingExpenses
16142454
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-8837015
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-1104726
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
466000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
650000
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
19800000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
108211
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123124
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-35815
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
35789
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
35789
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-35815
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-35815
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
35789
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
637500
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4165586
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1062500
CY2018Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
2273402
CY2017Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
267938
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
621
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
748
CY2018Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
CY2017Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
1224194
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36017
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
63429
CY2018 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1353613
CY2017 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1713759
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
254760
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
548343
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
125000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2018 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
5489850
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2703000
CY2018 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3500000
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000
CY2018 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
750
CY2017 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
895
CY2018 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
CY2017 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
175000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
835310
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
844557
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52035
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69405
CY2018 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-225408
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-116511
CY2018 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
3244248
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2055558
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1000000
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
CY2018 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
CY2017 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
250000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4414112
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21729605
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24104624
CY2017Q4 us-gaap Restricted Cash
RestrictedCash
50000
CY2016Q4 us-gaap Restricted Cash
RestrictedCash
50000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
50000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42960124
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31542684
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
125000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y153D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y164D
CY2018 us-gaap Stock Issued1
StockIssued1
CY2017 us-gaap Stock Issued1
StockIssued1
1868
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4301712
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4378588
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7219731
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.40
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2422500
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1070000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1760425
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13125000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8302500
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7232500
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.39
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.40
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.40
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.15
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.57
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.39
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y160D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y36D
CY2017 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
416667
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-13473175
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-5216538
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-3920374
CY2017Q4 us-gaap Subordinated Debt
SubordinatedDebt
625000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.5pt 0pt -2pt; text-align: left; text-indent: 37.5pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</div></div></div></div></div></div></div></div></div>
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66060038
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65413094
CY2018 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
66060038
CY2017 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65413094
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66060038
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65413094

Files In Submission

Name View Source Status
0001437749-19-007308-index-headers.html Edgar Link pending
0001437749-19-007308-index.html Edgar Link pending
0001437749-19-007308.txt Edgar Link pending
0001437749-19-007308-xbrl.zip Edgar Link pending
aclz-20181231.xml Edgar Link completed
aclz-20181231.xsd Edgar Link pending
aclz-20181231_cal.xml Edgar Link unprocessable
aclz-20181231_def.xml Edgar Link unprocessable
aclz-20181231_lab.xml Edgar Link unprocessable
aclz-20181231_pre.xml Edgar Link unprocessable
aclz20181231_10k.htm Edgar Link pending
ex_140459.htm Edgar Link pending
ex_140460.htm Edgar Link pending
ex_140461.htm Edgar Link pending
ex_140462.htm Edgar Link pending
ex_140650.htm Edgar Link pending
ex_140651.htm Edgar Link pending
ex_140652.htm Edgar Link pending
ex_140653.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending